NDATOPICALCREAM
Approved
Jul 2020
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
3/8 — Basic
WYNZORA (calcipotriene and betamethasone dipropionate) by PharmaIN is 3 analog and betamethasone dipropionate as a synthetic corticosteroid. First approved in 2020.
Drug data last refreshed 23h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
WYNZORA is a fixed-dose topical cream combining calcipotriene (vitamin D3 analog) and betamethasone dipropionate (synthetic corticosteroid) for the treatment of plaque psoriasis on the scalp and body. The exact mechanisms of action are not fully elucidated, though both components have established pharmacologic effects on psoriatic plaques. This combination approach leverages dual pathways to reduce inflammation and normalize skin cell differentiation.
Peak12.7 years to LOE
Product is in peak revenue phase with established market penetration; commercial teams are focused on optimization and share defense rather than heavy launch activities.
Mechanism of Action
3 analog and betamethasone dipropionate as a synthetic corticosteroid. However, while their pharmacologic and clinical effects are known, the exact mechanisms of their actions in the treatment of plaque psoriasis of the scalp and body are unknown.
Pharmacologic Class:
Vitamin D Analog
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
WYNZORA is a peak-lifecycle topical dermatology asset with stable market position and no active competitive threats, creating a lower-volatility career environment. Roles are concentrated in commercial optimization, market access navigation, and field execution rather than launch or development functions.
Brand Manager
Worked on WYNZORA at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.